Answers are grounded in this paper and cite their sources.
This paper reviews pharmacogenetic considerations in the use of oral antiplatelet therapy (aspirin and P2Y12 receptor blockers) for preventing thrombotic events.
Oral antiplatelet therapy with aspirin and a P2Y12 receptor blocker constitutes a major strategy to prevent thrombotic events in patients with arterial diseases. Among available P2Y12 receptor bloc...
No takes yet. Share an insight, caveat, or question.
Gurbel et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: